196
Views
0
CrossRef citations to date
0
Altmetric
Reviews

Obesity: A comorbidity-acquired immunodeficiency syndrome (CAIDS)

ORCID Icon
Pages 415-429 | Received 26 Jan 2022, Accepted 20 May 2022, Published online: 06 Jun 2022

References

  • World Health Organization. The Global Health Observatory. Noncommunicable diseases. https://www.who.int/data/gho/data/themes/noncommunicable-diseases. Accessed December 14, 2021.
  • Zhao X, Gang X, He G, et al. Obesity increases the severity and mortality of influenza and COVID-19: a systematic review and meta-analysis. Front Endocrinol. 2020;11:595109. doi:10.3389/fendo.2020.595109.
  • Kompaniyets L, Goodman AB, Belay B, et al. Body mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death - United States, March-December 2020. MMWR Morb Mortal Wkly Rep. 2021;70(10):355–361. doi:10.15585/mmwr.mm7010e4.
  • World Obesity. COVID-19 and Obesity: The 2021 Atlas. The cost of not addressing the global obesity crisis. March 2021. https://www.worldobesityday.org/assets/downloads/COVID-19-and-Obesity-The-2021-Atlas.pdf. Accessed December 14, 2021.
  • Kompaniyets L, Pennington AF, Goodman AB, et al. Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020-March 2021. Prev Chron Dis. 2021;18:E66. doi:10.5888/pcd18.210123.
  • US News. Americans with diabetes were hit hard by COVID pandemic. July 14, 2021. https://www.usnews.com/news/health-news/articles/2021-07-14/americans-with-diabetes-were-hit-hard-by-covid-pandemic. Accessed December 14, 2021.
  • Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723–1735. doi:10.1161/CIRCRESAHA.115.306825.
  • Fellinger P, Fuchs D, Wolf P, et al. Overweight and obesity in type 1 diabetes equal those of the general population. Wien Klin Wochenschr. 2019;131(3–4):55–60. doi:10.1007/s00508-018-1434-9.
  • Morgan OW, Bramley A, Fowlkes A, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One. 2010;5(3):e9694. doi:10.1371/journal.pone.0009694.
  • Charland KM, Buckeridge DL, Hoen AG, et al. Relationship between community prevalence of obesity and associated behavioral factors and community rates of influenza-related hospitalizations in the United States. Influenza Other Respir Viruses. 2013;7(5):718–728. doi:10.1111/irv.12019.
  • Domínguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA. 2009;302(17):1880–1887. doi:10.1001/jama.2009.1536.
  • Allard R, Leclerc P, Tremblay C, Tannenbaum TN. Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care. 2010;33(7):1491–1493. Juldoi:10.2337/dc09-2215.
  • Honce R, Schultz-Cherry S. Impact of obesity on influenza A virus pathogenesis, immune response, and evolution. Front Immunol. 2019;10:1071. doi:10.3389/fimmu.2019.01071.
  • Jubber AS. Respiratory complications of obesity. Int J Clin Pract. 2004;58(6):573–580. doi:10.1111/j.1368-5031.2004.00166.x.
  • Campitelli MA, Rosella LC, Kwong JC. The association between obesity and outpatient visits for acute respiratory infections in Ontario, Canada. Int J Obes. 2014;38(1):113–119. doi:10.1038/ijo.2013.57.
  • Tracey VV, De NC, Harper JR. Obesity and respiratory infection in infants and young children. Br Med J. 1971;1(5739):16–18. doi:10.1136/bmj.1.5739.16.
  • Karlsson EA, Beck MA. The burden of obesity on infectious disease. Exp Biol Med. 2010;235(12):1412–1424. doi:10.1258/ebm.2010.010227. PMID: 21127339.
  • Arslan E, Atilgan H, Yavaşoğlu I. The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med. 2009;20(7):695–697. doi:10.1016/j.ejim.2009.07.013.
  • Zhang H, Li X, Xin H, et al. Association of body mass index with the tuberculosis infection: a population-based study among 17796 adults in rural China. Sci Rep. 2017;7:41933. doi:10.1038/srep41933.
  • Herwaldt LA, Cullen JJ, French P, et al. Preoperative risk factors for nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol. 2004;25(6):481–484. doi:10.1086/502426.
  • Karjala Z, Neal D, Rohrer J. Association between HSV1 seropositivity and obesity: data from the National Health and Nutritional Examination Survey, 2007-2008. PLoS One. 2011;6(5):e19092. doi:10.1371/journal.pone.0019092.
  • Serrano M, Moreno M, Bassols J, et al. Coxsackie and adenovirus receptor is increased in adipose tissue of obese subjects: a role for adenovirus infection? J Clin Endocrinol Metab. 2015;100(3):1156–1163. doi:10.1210/jc.2014-3791.
  • Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9(5):367–377. doi:10.1038/nrm2391.
  • Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117(1):175–184. doi:10.1172/JCI29881.
  • Andersen CJ, Murphy KE, Fernandez ML. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016;7(1):66–75. doi:10.3945/an.115.010207.
  • Pérez-Galarza J, Prócel C, Cañadas C, et al. Immune response to SARS-CoV-2 infection in obesity and T2D: literature review. Vaccines (Basel). 2021;9(2):102. doi:10.3390/vaccines9020102.
  • Kanneganti TD, Dixit VD. Immunological complications of obesity. Nat Immunol. 2012;13(8):707–712. doi:10.1038/ni.2343.
  • Ghanim H, Aljada A, Hofmeyer D, et al. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation. 2004;110(12):1564–1571. doi:10.1161/01.CIR.0000142055.53122.FA.
  • Tsalamandris S, Antonopoulos AS, Oikonomou E, et al. The role of inflammation in diabetes: current concepts and future perspectives. Eur Cardiol. 2019;14(1):50–59. doi:10.15420/ecr.2018.33.1.
  • Sheridan PA, Paich HA, Handy J, et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes. 2012;36(8):1072–1077. doi:10.1038/ijo.2011.208.
  • Stefan N, Birkenfeld AL, Schulze MB. Global pandemics interconnected - obesity, impaired metabolic health and COVID-19. Nat Rev Endocrinol. 2021;17(3):135–149. doi:10.1038/s41574-020-00462-1.
  • Yang H, Youm YH, Vandanmagsar B, et al. Obesity accelerates thymic aging. Blood. 2009;114(18):3803–3812. doi:10.1182/blood-2009-03-213595.
  • Weitman ES, Aschen SZ, Farias-Eisner G, et al. Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes. PLoS One. 2013;8(8):e70703. doi:10.1371/journal.pone.0070703.
  • O’Rourke RW, Kay T, Scholz MH, et al. Alterations in T-cell subset frequency in peripheral blood in obesity. Obes Surg. 2005;15(10):1463–1468. doi:10.1381/096089205774859308.
  • van der Weerd K, Dik WA, Schrijver B, et al. Morbidly obese human subjects have increased peripheral blood CD4+ T cells with skewing toward a Treg- and Th2-dominated phenotype. Diabetes. 2012;61(2):401–408. doi:10.2337/db11-1065.
  • Urra JM, Cabrera CM, Porras L, Ródenas I. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients. Clin Immunol. 2020;217:108486. doi:10.1016/j.clim.2020.108486.
  • Peng X, Ouyang J, Isnard S, et al. Sharing CD4+ T cell loss: when COVID-19 and HIV collide on immune system. Front Immunol. 2020;11:596631. doi:10.3389/fimmu.2020.596631.
  • Wen XS, Jiang D, Gao L, et al. Clinical characteristics and predictive value of lower CD4+T cell level in patients with moderate and severe COVID-19: a multicenter retrospective study. BMC Infect Dis. 2021;21(1):57. doi:10.1186/s12879-020-05741-w.
  • Zhang H, Wu T. CD4 + T, CD8 + T counts and severe COVID-19: a meta-analysis. J Infect. 2020;81(3):e82–e84. doi:10.1016/j.jinf.2020.06.036.
  • Francisco V, Pino J, Campos-Cabaleiro V, et al. Obesity, fat mass and immune system: role for leptin. Front Physiol. 2018;9(640):640. doi: 10.3389/fphys.2018.00640.
  • Luo Y, Liu M. Adiponectin: a versatile player of innate immunity. J Mol Cell Biol. 2016;8(2):120–128. doi:10.1093/jmcb/mjw012.
  • Lecube A, Pachón G, Petriz J, et al. Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS One. 2011;6(8):e23366. doi:10.1371/journal.pone.0023366.
  • Karlsson EA, Sheridan PA, Beck MA. Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells. J Nutr. 2010;140(9):1691–1697. doi:10.3945/jn.110.123653.
  • Ocak S, Eskiocak AF. The evaluation of immune responses to hepatitis B vaccination in diabetic and non-diabetic haemodialysis patients and the use of tetanus toxoid. Nephrology (Carlton). 2008;13(6):487–491. doi:10.1111/j.1440-1797.2008.00936.x.
  • Weber DJ, Rutala WA, Samsa GP, et al. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA. 1985;254(22):3187–3189. doi:10.1001/jama.1985.03360220053027.
  • Weber DJ, Rutala WA, Samsa GP, et al. Impaired immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med. 1986;314(21):1393. doi:10.1056/NEJM198605223142120.
  • Yang S, Tian G, Cui Y, et al. Factors influencing immunologic response to hepatitis B vaccine in adults. Sci Rep. 2016;6:27251. doi:10.1038/srep27251.
  • Young KM, Gray CM, Bekker LG. Is obesity a risk factor for vaccine non-responsiveness? PLoS One. 2013;8(12):e82779. doi:10.1371/journal.pone.0082779.
  • Estévez ZC, Betancourt AA, Muzio González V, et al. Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults. Biologicals. 2007;35(2):115–122. doi:10.1016/j.biologicals.2006.06.001.
  • Fan W, Chen XF, Shen C, et al. Hepatitis B vaccine response in obesity: a meta-analysis. Vaccine. 2016;34(40):4835–4841. doi:10.1016/j.vaccine.2016.08.027.
  • Roome AJ, Walsh SJ, Cartter ML, Hadler JL. Hepatitis B vaccine responsiveness in Connecticut public safety personnel. JAMA. 1993;270(24):2931–2934. doi:10.1001/jama.1993.03510240043029.
  • Averhoff F, Mahoney F, Coleman P, et al. Immunogenicity of hepatitis B vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med. 1998;15(1):1–8. doi:10.1016/S0749-3797(98)00003-8.
  • Simó Miñana J, Gaztambide Ganuza M, Fernández Millán P, Peña Fernández M. Hepatitis B vaccine immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination. Vaccine. 1996;14(2):103–106. doi:10.1016/0264-410x(95)00176-2.
  • Painter SD, Ovsyannikova IG, Poland GA. The weight of obesity on the human immune response to vaccination. Vaccine. 2015;33(36):4422–4429. doi:10.1016/j.vaccine.2015.06.101.
  • Van der Wielen M, Van Damme P, Chlibek R, et al. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors. Vaccine. 2006;24(26):5509–5515. doi:10.1016/j.vaccine.2006.04.016.
  • Reuman PD, Kubilis P, Hurni W, et al. The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults. Vaccine. 1997;15(10):1157–1161. doi:10.1016/S0264-410X(96)00310-6.
  • Eliakim A, Swindt C, Zaldivar F, et al. Reduced tetanus antibody titers in overweight children. Autoimmunity. 2006;39(2):137–141. doi:10.1080/08916930600597326.
  • Banga N, Guss P, Banga A, Rosenman KD. Incidence and variables associated with inadequate antibody titers after pre-exposure rabies vaccination among veterinary medical students. Vaccine. 2014;32(8):979–983. doi:10.1016/j.vaccine.2013.
  • Talbot HK, Coleman LA, Crimin K, et al. Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. Vaccine. 2012;30(26):3937–3943. doi:10.1016/j.vaccine.2012.03.071.
  • Neidich SD, Green WD, Rebeles J, et al. Increased risk of influenza among vaccinated adults who are obese. Int J Obes. 2017;41(9):1324–1330. doi:10.1038/ijo.2017.131.
  • Green WD, Beck MA. Obesity impairs the adaptive immune response to influenza virus. Ann Am Thorac Soc. 2017;14(Supplement_5):S406–S409. doi:10.1513/AnnalsATS.201706-447AW.
  • Pellini R, Venuti A, Pimpinelli F, et al. Obesity may hamper SARS-CoV-2 vaccine immunogenicity. MedRxiv. 2021. preprint doi:10.1101/2021.02.24.21251664. Accessed December 14, 2021.
  • Paich HA, Sheridan PA, Handy J, et al. Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver Spring). 2013;21(11):2377–2386. doi:10.1002/oby.20383.
  • Sell H, Habich C, Eckel J. Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol. 2012;8(12):709–716. doi:10.1038/nrendo.2012.114.
  • White SJ, Taylor MJ, Hurt RT, et al. Leptin-based adjuvants: an innovative approach to improve vaccine response. Vaccine. 2013;31(13):1666–1672. doi:10.1016/j.vaccine.2013.01.032.
  • Alti D, Sambamurthy C, Kalangi SK. Emergence of leptin in infection and immunity: scope and challenges in vaccines formulation. Front Cell Infect Microbiol. 2018;8:147. doi:10.3389/fcimb.2018.00147.
  • Dinelli MI, Moraes-Pinto MI. Seroconvertion to hepatitis B vaccine after weight reduction in obese non-responder. Rev Inst Med Trop Sao Paulo. 2008;50(2):129–130. doi:10.1590/s0036-46652008000200013.
  • Dixit VD. Impact of immune-metabolic interactions on age-related thymic demise and T cell senescence. Semin Immunol. 2012;24(5):321–330. doi:10.1016/j.smim.2012.04.002.
  • Dixit VD. Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span. J Leukoc Biol. 2008;84(4):882–892. doi:10.1189/jlb.0108028.
  • Yang H, Youm YH, Dixit VD. Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution. J Immunol. 2009;183(5):3040–3052. doi:10.4049/jimmunol.0900562.
  • Siopis G. Secrets to longevity: the Methuselahs that survived COVID-19. J Am Geriatr Soc. 2021;69(10):2788–2790. doi:10.1111/jgs.17400.
  • Siopis G. Supercentenarians that survived COVID-19. Aging Dis. 2021;12(7):1539–1540. doi:10.14336/AD.2021.0806.
  • Kelishadi R, Roufarshbaf M, Soheili S, et al. Association of childhood obesity and the immune system: a systematic review of reviews. Child Obes. 2017;13(4):332–346. doi:10.1089/chi.2016.0176.
  • Fang X, Henao-Mejia J, Henrickson SE. Obesity and immune status in children. Curr Opin Pediatr. 2020;32(6):805–815. doi:10.1097/MOP.0000000000000953.
  • Gielen M, Hageman GJ, Antoniou EE, et al. Body mass index is negatively associated with telomere length: a collaborative cross-sectional meta-analysis of 87 observational studies. Am J Clin Nutr. 2018;108(3):453–475. doi:10.1093/ajcn/nqy107.
  • Shirakawa K, Sano M. T cell immunosenescence in aging, obesity, and cardiovascular disease. Cells. 2021;10(9):2435. doi:10.3390/cells10092435.
  • World Health Organization. Obesity. Updated 9 June 2021. https://www.who.int/news-room/facts-in-pictures/detail/6-facts-on-obesity. Accessed April 4, 2022.
  • Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects), Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet. 2014;383:970-983. doi:10.1016/S0140-6736(13)61836-X.
  • World Health Organisation. Obesity and overweight. Updated on June 9, 2021. Available from https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed December 14, 2021.
  • Siopis G. The case for promoting physical activity amidst the COVID-19 pandemic. J Sci Med Sport. 2021;24(4):327–328. doi:10.1016/j.jsams.2020.11.019.
  • Siopis G. The case for promoting physical activity amidst the COVID-19 pandemic. An update. J Sci Med Sport. 2021;24(9):900–901. doi:10.1016/j.jsams.2021.03.014.
  • Hoong CWS, Hussain I, Aravamudan VM, et al. Obesity is associated with poor Covid-19 outcomes: a systematic review and meta-analysis. Horm Metab Res. 2021;53(02):85–93. doi:10.1055/a-1326-2125.
  • Du Y, Lv Y, Zha W, et al. Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: a dose-response meta-analysis. Metabolism. 2021;117:154373. doi:10.1016/j.metabol.2020.154373.
  • Kristensen NM, Gribsholt SB, Andersen AL, et al. Obesity augments the disease burden in COVID-19: updated data from an umbrella review. Clin Obes. 2022:e12508. doi:10.1111/cob.12508.
  • Siopis G. Elite athletes maintain peak performance after testing positive for SARS-CoV-2. J Sci Med Sport. 2021; doi:10.1016/j.jsams.2021.08.010.
  • Siopis G. SARS-CoV-2 does not affect long-term performance of top-level elite athletes. Curr Sports Med Rep. 2021;20(11):569–571. doi:10.1249/JSR.0000000000000900.
  • Siopis G. Athletic performance is not affected by SARS-CoV-2. Sci Sports. 2021; doi:10.1016/j.scispo.2021.08.002.
  • National Institutes of Health. National Human Genome Research Institute. Genome-Wide Association Studies. Fact Sheet. August 2020. https://www.genome.gov/about-genomics/fact-sheets/Genome-Wide-Association-Studies-Fact-Sheet. Accessed December 14, 2021.
  • Centers for Disease and Control Prevention. Genomics and Precision Health. Genes and Obesity. https://www.cdc.gov/genomics/resources/diseases/obesity/obesedit.htm. Accessed December 14, 2021.
  • Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197–206. doi:10.1038/nature14177.
  • Yang W, Kelly T, He J. Genetic epidemiology of obesity. Epidemiol Rev. 2007;29:49–61. doi:10.1093/epirev/mxm004.
  • Hainer V, Toplak H, Mitrakou A. Treatment modalities of obesity: what fits whom? Diabetes Care. 2008;31(Suppl 2):S269–S77. doi:10.2337/dc08-s265.
  • Kilpeläinen TO, Qi L, Brage S, et al. Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med. 2011;8(11):e1001116. doi:10.1371/journal.pmed.1001116.
  • Veerman JL. On the futility of screening for genes that make you fat. PLoS Med. 2011;8(11):e1001114. doi:10.1371/journal.pmed.1001114.
  • Ponterio E, Gnessi L. Adenovirus 36 and obesity: an overview. Viruses. 2015;7(7):3719–3740. doi:10.3390/v7072787.
  • Iddir M, Brito A, Dingeo G, et al. Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis. Nutrients. 2020;12(6):1562. doi:10.3390/nu12061562.
  • Duggal NA, Niemiro G, Harridge SDR, et al. Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity? Nat Rev Immunol. 2019;19(9):563–572. doi:10.1038/s41577-019-0177-9.
  • Itani O, Jike M, Watanabe N, Kaneita Y. Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression. Sleep Med. 2017;32:246–256. doi:10.1016/j.sleep.2016.08.006.
  • Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature. 2008;453(7196):783–787. doi:10.1038/nature06902.
  • Jo J, Gavrilova O, Pack S, et al. Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth. PLoS Comput Biol. 2009;5(3):e1000324. doi:10.1371/journal.pcbi.1000324.
  • White U, Ravussin E. Dynamics of adipose tissue turnover in human metabolic health and disease. Diabetologia. 2019;62(1):17–23. doi:10.1007/s00125-018-4732-x.
  • Stenkula KG, Erlanson-Albertsson C. Adipose cell size: importance in health and disease. Am J Physiol Regul Integr Comp Physiol. 2018;315(2):R284–R295. doi:10.1152/ajpregu.00257.2017.
  • Luzi L, Radaelli MG. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic. Acta Diabetol. 2020;57(6):759–764. doi:10.1007/s00592-020-01522-8.
  • World Obesity. Prevalence of Obesity. https://www.worldobesity.org/about/about-obesity/prevalence-of-obesity. Accessed March 3, 2022.
  • Agha M, Agha R. The rising prevalence of obesity: part A: impact on public health. Int J Surg Oncol (NY). 2017;2(7):e17. doi:10.1097/IJ9.0000000000000017.
  • Nutrition and Food Sciences Database. Adult Obesity Rates Predicted to Rise to 60-80% by 2050. Available from https://www.cabi.org/nutrition/news/12612. Accessed on March 3, 2022+.
  • The guardian. UK government may start offering financial rewards for becoming healthier. https://www.theguardian.com/society/2021/mar/04/uk-government-may-start-offering-financial-rewards-for-becoming-healthier. Accessed December 14, 2021.
  • Hua Y, Lou YX, Li C, , et al. Clinical outcomes of bariatric surgery - Updated evidence. Obes Res Clin Pract. 2022;16(1):1–9. doi:10.1016/j.orcp.2021.11.004.
  • Pulipati VP, Pannain S. Pharmacotherapy of obesity in complex diseases. Clin Obes. 2022;12(1):e12497. doi:10.1111/cob.12497.
  • Boppre G, Diniz-Sousa F, Veras L, et al. Can exercise promote additional benefits on body composition in patients with obesity after bariatric surgery? A systematic review and meta-analysis of randomized controlled trials. Obes Sci Pract. 2022;8(1):112–123. doi:10.1002/osp4.542.
  • Weyh C, Krüger K, Strasser B. Physical activity and diet shape the immune system during aging. Nutrients. 2020;12(3):622. doi:10.3390/nu12030622.
  • Scheffer DDL, Latini A. Exercise-induced immune system response: anti-inflammatory status on peripheral and central organs. Biochim Biophys Acta Mol Basis Dis. 2020;1866(10):165823. doi:10.1016/j.bbadis.2020.165823.
  • Petrelli F, Luciani A, Perego G, et al. Therapeutic and prognostic role of vitamin D for COVID-19 infection: a systematic review and meta-analysis of 43 observational studies. J Steroid Biochem Mol Biol. 2021;211:105883. doi:10.1016/j.jsbmb.2021.105883.
  • Wang L, Song Y. Efficacy of zinc given as an adjunct to the treatment of severe pneumonia: a meta-analysis of randomized, double-blind and placebo-controlled trials. Clin Respir J. 2018;12(3):857–864. doi:10.1111/crj.12646.
  • Michalek RD, Gerriets VA, Jacobs SR, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol. 2011;186(6):3299–3303. doi:10.4049/jimmunol.1003613.
  • Pearce EL, Walsh MC, Cejas PJ, et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature. 2009;460(7251):103–107. doi:10.1038/nature08097.
  • Araki K, Turner AP, Shaffer VO, et al. mTOR regulates memory CD8 T-cell differentiation. Nature. 2009;460(7251):108–112. Jul 2doi:10.1038/nature08155.
  • Rao RR, Li Q, Odunsi K, Shrikant PA. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity. 2010;32(1):67–78. doi:10.1016/j.immuni.2009.10.010.
  • Batatinha HAP, Biondo LA, Lira FS, et al. Nutrients, immune system, and exercise: where will it take us? Nutrition. 2019;61:151–156. doi:10.1016/j.nut.2018.09.019.
  • Childs CE, Calder PC, Miles EA. Diet and immune function. Nutrients. 2019;11:1933. doi:10.3390/nu11081933.
  • Wu PY, Chen KM, Tsai WC. The Mediterranean dietary pattern and inflammation in older adults: a systematic review and meta-analysis. Adv Nutr. 2021;12(2):363–373. doi:10.1093/advances/nmaa116.
  • Chae JS, Paik JK, Kang R, et al. Mild weight loss reduces inflammatory cytokines, leukocyte count, and oxidative stress in overweight and moderately obese participants treated for 3 years with dietary modification. Nutr Res. 2013;33(3):195–203. doi:10.1016/j.nutres.2013.01.005.
  • Sheu WH, Chang TM, Lee WJ, et al. Effect of weight loss on proinflammatory state of mononuclear cells in obese women. Obesity (Silver Spring). 2008;16(5):1033–1038. doi:10.1038/oby.2008.37.
  • Poles J, Karhu E, McGill M, et al. The effects of twenty-four nutrients and phytonutrients on immune system function and inflammation: a narrative review. J Clin Transl Res. 2021;7(3):333–376.
  • Koelman L, Egea Rodrigues C, Aleksandrova K. Effects of dietary patterns on biomarkers of inflammation and immune responses: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr. 2022;13(1):101–115. doi:10.1093/advances/nmab086.
  • Dimitrov S, Hulteng E, Hong S. Inflammation and exercise: inhibition of monocytic intracellular TNF production by acute exercise via β2-adrenergic activation. Brain Behav Immun. 2017;61:60–68. doi:10.1016/j.bbi.2016.12.017.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.